Bei Pal habe ich die Reissleine gezogen. Wenn Pal nicht steigen kann bei steigenden Palladium Preisen, dann bedeuted dies, dass eine weitere Verwässerung ansteht.
Bei DECN bleibe ich drin. Habe es mit 500 % Profit nicht verkauft - schade im Rückblick - aber mir gefällt deren Geschäftsmodell.
Die 10K und 10Q erwarte ich in Kürze - die Gesellschaft hat übrigens die Verzögerung erklärt - plus dies habe ich heute in einem der Blogs gesehen. Die sind nicht so untätig in der Ruhephase.
On March 18, 2014, the Company entered into a GenStrip Technology Buyout agreement wherein the company agreed to purchase all of the intellectual property
On March 25, 2014, the Company entered into a three-year international distributor agreement whereby it appointed a distributor on an exclusive basis to purchase and resell the Genstrip product in the territory of Russia for consideration of $75,000, of which $50,000 is for the exclusive rights, and $25,000 is payment to be applied towards the first order. Another $25,000 is due July 1, 2014, of which the amount will be applied towards the first order, and the final payment of $50,000 is due September 30, 2014, of which the amount will be applied towards the first order. Within 12 months of product approval in Russia, the distributor is required to reach US$2,000,000 in purchases to maintain exclusivity for the next 12 months.
On March 31, 2014 the company made its first deliveries of it Genstrip products to Chain Drug Marketing Association (CDMA) of Novi, Michgan, a trade and purchasing organization for over 5,000 smaller chain pharmacies in the U.S. CDMA has represented chain pharmacies since 1926.
On April 11, 2014 the company became a private label supplier of its Genstrip product to Meijer, a large supermarket chain, with stores primarily located in the upper midwest.
|